Advanced Stent Technologies (AST; Pleasanton, California) has named several new senior managers. Eitan Konstantino, PhD, has been named chief executive officer and chief operating officer. He previously was chief technical officer at ByPass Ltd., an Israeli firm. Merrill Weber has been promoted to president. He joined AST in November of last year as executive vice president-corporate affairs and general counsel. Prior to joining AST, Weber was a principal of a securities firm and was primarily engaged in raising capital for companies in diverse fields, including medical devices. Nimrod Tzori becomes chief technology officer. He previously was vice president, research and development, for CoreFlow Ltd. Ilana Odess has been named vice president, marketing and sales. She was business development and marketing director for Europe, the Middle East and Africa at Cordis. Michal Geva has been appointed vice president, regulatory affairs, clinical affairs and quality assurance. She was director, quality assurance and regulatory affairs, at ByPass Ltd. Tanhum Feld was named director, research and development, joining the firm from Bypass Ltd. Noam Mizrahi was named director of new technologies after serving as technology and engineering manager at CardioDex Ltd. In addition, XuFan Tseng, PhD, has been recruited to coordinate the company's efforts in the drug-eluting stents, a new program that includes what ATS calls "a unique technology for direct targeted drug delivery utilizing reloadable stents." Tseng was a postdoctoral fellow at the Buck Institute for Age Research and previously was a postdoctoral fellow with the division of oncology/hematology at the School of Medicine of the University of California, San Francisco. Founded in October 1998, ATS initially is in development and clinical testing of the SLK-View coronary stent and delivery system.

Thomas Soukup has been named chief scientist for Synovis Interventional Solutions, a subsidiary of Bio-Vascular (both St. Paul, Minnesota). Soukup is rejoining the company after serving as vice president of engineering for two years at Biomec Cardiovascular. Synovis develops complex micro-wire forms and plastic components used in interventional devices for cardiac rhythm management, neurostimulation and vascular procedures. Bio-Vascular develops devices for surgical and interventional treatments.

No Comments